July 14, 2020: Potential For Cancer Agents in the Treatment of COVID-19: COVID-19 Recovery, the Road Ahead

Burt Zweigenhaft, PhD, D.Litt

July 14, 2020: Potential For Cancer Agents in the Treatment of COVID-19: COVID-19 Recovery, the Road Ahead

AVBCC COVID-19 Webcast Series Replays, COVID-19

Featuring:

David DeRemer, PharmD, BCOP, FCCP, FHOPA

Clinical Associate Professor
University of Florida College Pharmacy

Michael Joyner, MD

Professor, Mayo Clinic

Maurie Markman, MD

President
Medicine & Science
Cancer Treatment Centers of America

Kevin O’Hayer, MD, PhD

Senior Director, Immuno-Oncology
Incyte Corporation

Bhavesh Shah, RPh, BCOP

Director of Specialty and Hematology/Oncology Pharmacy, Boston Medical Center

Mark Sloan, MD

Associate Professor of Medicine
Boston University School of Medicine

Burt Zweigenhaft, PhD, D.Litt

Editor-in-Chief, VBCC;
Executive Vice President, FFF Enterprises;
Executive Director and Co-Founder, Association for Value-Based Cancer Care

As we learn more about the complicated behavior of the COVID-19 virus, we have come to understand that overactivation of the patient’s own immune system can often be the most dangerous factor. In this webcast, top cancer experts discuss the latest studies investigating using anti-cancer therapies as treatments for COVID-19. What are some of the options and where does the research stand today?

July 14, 2020: Potential For Cancer Agents in the Treatment of COVID-19: COVID-19 Recovery, the Road Ahead

Featuring:

Top Trending Articles

Stay In The Know

July 14, 2020: Potential For Cancer Agents in the Treatment of COVID-19: COVID-19 Recovery, the Road Ahead

Featuring:

Related Articles

Top Trending Articles

Stay In The Know